Image Image Image Image Image Image Image Image Image Image

Northeast Times | April 4, 2020

Scroll to top

Top

From CDC – COVID 19 Risk Assessment

From CDC – COVID 19 Risk Assessment

Risk depends on characteristics of the virus, including how well it spreads between people; the severity of resulting illness; and the medical or other measures available to control the impact of the virus (for example, vaccines or medications that can treat the illness) and the relative success of these. In the absence of vaccine or treatment medications, nonpharmaceutical interventions become the most important response strategy. These are community interventions that can reduce the impact of disease.

The risk from COVID-19 to Americans can be broken down into risk of exposure versus risk of serious illness and death.

Risk of exposure:

The immediate risk of being exposed to this virus is still low for most Americans, but as the outbreak expands, that risk will increase. Cases of COVID-19 and instances of community spread are being reported in a growing number of states.
People in places where ongoing community spread of the virus that causes COVID-19 has been reported are at elevated risk of exposure, with the level of risk dependent on the location.
Healthcare workers caring for patients with COVID-19 are at elevated risk of exposure.
Close contacts of persons with COVID-19 also are at elevated risk of exposure.
Travelers returning from affected international locations where community spread is occurring also are at elevated risk of exposure, with level of risk dependent on where they traveled.
Risk of Severe Illness:

Early information out of China, where COVID-19 first started, shows that some people are at higher risk of getting very sick from this illness. This includes:

Older adults, with risk increasing by age.
People who have serious chronic medical conditions like:
Heart disease
Diabetes
Lung disease
CDC has developed guidance to help in the risk assessment and management of people with potential exposures to COVID-19.

https://www.cdc.gov/nonpharmaceutical-interventions/index.html
https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html
https://www.cdc.gov/coronavirus/2019-ncov/hcp/assess-manage-risk.html